Abstract
The absence of a rapidly available sensitive diagnostic test represents an important limitation in the management of patients with suspected stroke. The aim of the present study was to investigate the accuracy of a novel test that measures blood-borne biomarkers (Triage® Stroke Panel, TSP, Biosite Inc.) and to compare its diagnostic utility with that of standardized stroke scales used in the triage of patients with suspected stroke. Methods: Consecutive patients with suspected stroke presenting to the emergency department of three Italian medical centers underwent ‘triage’ by a dedicated nurse and had blood drawn for TSP testing.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
